PHARMACODYNAMIC EFFECTS AND SAFETY OF VERINURAD (RDEA3170) IN COMBINATION WITH FEBUXOSTAT VERSUS FEBUXOSTAT ALONE IN ADULTS WITH GOUT: A PHASE 2A, OPEN-LABEL STUDY

被引：0
|
作者：
Fleischmann, R. [1 ]
Winkle, P. [2 ]
Hall, J. [3 ]
Valdez, S. [3 ]
Liu, S. [3 ]
Yan, X. [3 ]
Hicks, L. [3 ]
Hernandez-Illas, M. [4 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75390 USA
[2] Anaheim Clin Trials, Anaheim, CA USA
[3] Ardea Biosci Inc, San Diego, CA USA
[4] 4QPS MRA Miami Clin Res, Miami, FL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5367
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0434
引用
收藏
页码：371 / 371
页数：1
相关论文
共 50 条
  • [1] PHARMACODYNAMICS, PHARMACOKINETICS, AND SAFETY OF VERINURAD (RDEA3170) IN COMBINATION WITH FEBUXOSTAT VERSUS FEBUXOSTAT ALONE AND VERINURAD ALONE IN JAPANESE ADULTS WITH GOUT OR ASYMPTOMATIC HYPERURICEMIA: A PHASE 2A, OPEN-LABEL STUDY
    Shiramoto, M.
    Liu, S.
    Shen, Z.
    Hall, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 371 - 372
  • [2] Pharmacodynamic Effects and Safety of Verinurad in Combination with Febuxostat Versus Febuxostat Alone in Adults with Gout: A Phase 2a, Open-Label Study
    Fleischmann, Roy
    Winkle, Peter
    Hall, Jesse
    Valdez, Shakti
    Liu, Sha
    Yan, Xiaohong
    Hicks, Liz
    Hernandez-Illas, Martha
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] PHARMACODYNAMIC EFFECTS AND SAFETY OF VERINURAD (RDEA3170) IN COMBINATION WITH ALLOPURINOL VERSUS ALLOPURINOL ALONE IN ADULTS WITH GOUT: A PHASE 2A, OPEN-LABEL STUDY
    Fleischmann, R.
    Winkle, P.
    Miner, J. N.
    Yan, X.
    Hicks, L.
    Valdez, S.
    Hall, J.
    Hernandez-Illas, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1364 - 1364
  • [4] Pharmacodynamics, Pharmacokinetics, and Safety of Verinurad in Combination with Febuxostat Versus Febuxostat Alone and Verinurad Alone in Japanese Adults with Gout or Asymptomatic Hyperuricemia: A Phase 2a, Open-Label Study
    Shiramoto, Masanari
    Sugeno, Masatoshi
    Liu, Sha
    Shen, Zangong
    Hall, Jesse
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study
    Fleischmann, Roy
    Winkle, Peter
    Hall, Jesse
    Valdez, Shakti
    Liu, Sha
    Yan, Xiaohong
    Hicks, Liz
    Lee, Caroline
    Miner, Jeffrey N.
    Gillen, Michael
    Hernandez-Illas, Martha
    RMD OPEN, 2018, 4 (01):
  • [6] Pharmacodynamic Effects and Safety of Verinurad in Combination with Allopurinol Versus Allopurinol Alone in Adults with Gout: A Phase 2a, Open-Label Study
    Fleischmann, Roy
    Winkle, Peter
    Hall, Jesse
    Yan, Xiaohong
    Miner, Jeffrey N.
    Hicks, Liz
    Valdez, Shakti
    Hernandez-Illas, Martha
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study
    Shiramoto, Masanari
    Liu, Sha
    Shen, Zancong
    Yan, Xiaohong
    Yamamoto, Amy
    Gillen, Michael
    Ito, Yasushi
    Hall, Jesse
    RHEUMATOLOGY, 2018, 57 (09) : 1602 - 1610
  • [8] Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study
    Fleischmann, Roy
    Winkle, Peter
    Miner, Jeffrey N.
    Yan, Xiaohong
    Hicks, Liz
    Valdez, Shakti
    Hall, Jesse
    Liu, Sha
    Shen, Zancong
    Gillen, Michael
    Hernandez-Illas, Martha
    RMD OPEN, 2018, 4 (01):
  • [9] PHARMACODYNAMIC AND PHARMACOKINETIC STUDY OF VERINURAD (RDEA3170) IN ADULT MALE SUBJECTS WITH MILD, MODERATE, AND SEVERE RENAL IMPAIRMENT: A PHASE 1, OPEN-LABEL STUDY
    Smith, W. B.
    Hall, J.
    Berg, J. K.
    Kazimir, M.
    Yamamoto, A.
    Walker, S.
    Lee, C.
    Marbury, T. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 371 - 371
  • [10] A MULTICENTRE OPEN-LABEL PHARMACOKINETIC-PHARMACODYNAMIC (PKPD) STUDY OF FEBUXOSTAT IN PATIENTS WITH CHRONIC GOUT
    Kamel, B.
    Stocker, S.
    Graham, G.
    Carland, J.
    Parker, M.
    Williams, K.
    Pile, K.
    Portek, I
    McGill, N.
    Day, R.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 14 - 14
12345